BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 3736967)

  • 1. [Preoperative determination of serum immunoglobulins in colorectal cancer: correlation between staging and course of the disease].
    Secco GB; Frassetto GL; Venturini M; Santi F; Fardelli R; Terrizzi A
    Minerva Dietol Gastroenterol; 1986; 32(2):183-6. PubMed ID: 3736967
    [No Abstract]   [Full Text] [Related]  

  • 2. [Colorectal neoplasms: preoperative determination of GICA].
    Bussone R; Sanlorenzo M; Natta F; Rocca N; Caldarola B
    Minerva Chir; 1987 Oct; 42(20):1655-6. PubMed ID: 3479706
    [No Abstract]   [Full Text] [Related]  

  • 3. [Prognostic significance of preoperative CEA titers in colorectal cancer].
    Schneider K; Metzger U; Joller H; Grob PJ; Largiadèr F
    Helv Chir Acta; 1983 Mar; 49(6):843-7. PubMed ID: 6862990
    [No Abstract]   [Full Text] [Related]  

  • 4. Preoperative carcinoembryonic antigen and prognosis in patients with colorectal cancer.
    Onetto M; Paganuzzi M; Secco GB; Fardelli R; Santi F; Rovida S; Ferrara GB
    Biomed Pharmacother; 1985; 39(7):392-5. PubMed ID: 3830268
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Preoperative investigations for metastatic staging of colon and rectal cancer across multiple centres--what is current practice?
    Kosmider S; Stella DL; Field K; Moore M; Ananda S; Oakman C; Singh M; Gibbs P
    Colorectal Dis; 2009 Jul; 11(6):592-600. PubMed ID: 18624816
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Clinico-pathological classification of colorectal cancer].
    Zhang SQ; Wu JM; Su YY
    Zhonghua Wai Ke Za Zhi; 1983 Jan; 21(1):49-50, 64. PubMed ID: 6851785
    [No Abstract]   [Full Text] [Related]  

  • 7. [Correlation between the levels of CA 19-9 and Ca-50 in colorectal cancer].
    Lamíquiz Vallejo A; Domínguez Merru-Urrutia MJ; Loizate Totoricagüena A; Cruz Fombellida Cortázar J
    Med Clin (Barc); 1988 Jan; 90(1):42. PubMed ID: 3162290
    [No Abstract]   [Full Text] [Related]  

  • 8. [Follow-up of colorectal neoplasms: use of TPA].
    Citone G; Catani M; Procacciante F; Perri S; Pronio A; Ribotta G
    Minerva Chir; 1987 Oct; 42(20):1625-6. PubMed ID: 3683924
    [No Abstract]   [Full Text] [Related]  

  • 9. Serum immunoglobulins in colorectal cancer.
    Slater G; Papatestas AE; Shafir M; Aufses AH
    J Surg Oncol; 1980; 14(2):167-71. PubMed ID: 7392639
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Importance of CEA determination in colo-rectal neoplasms].
    Pezcoller C; Ricchi E; Briccoli A; Saviano MS; Ferrara F; De Palma M; Guernelli N
    Minerva Chir; 1984 Feb; 39(3):153-60. PubMed ID: 6728213
    [No Abstract]   [Full Text] [Related]  

  • 11. [Histological changes in the colonic and rectal cancer stroma observed in patients following immunopotentiation with thymus extract (TFX)].
    Urban A; Turowski G; Cybulski L
    Patol Pol; 1977; 28(1):47-59. PubMed ID: 854368
    [No Abstract]   [Full Text] [Related]  

  • 12. Carcinoembryonic antigen: usefulness as a postsurgical method in the detection of recurrence in Dukes stages B2 and C colorectal cancers.
    Koch M; Washer G; Gaedke H; McPherson TA
    J Natl Cancer Inst; 1982 Oct; 69(4):813-5. PubMed ID: 6956758
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Statistical evaluation of globulin fractions in the course of malignant neoplasia].
    Abeatici S; Lamarca S; Sassi I
    Arch Sci Med (Torino); 1971; 128(4):231-5. PubMed ID: 5154435
    [No Abstract]   [Full Text] [Related]  

  • 14. [Preoperative determination of TPA in colorectal neoplasms. Evaluation of a group consisting of 75 patients].
    Ramella A; Bussone R; Sanlorenzo M; Natta F; Caldarola B; Schirripa C; Giani R; Pecchio F; Rocca N
    Minerva Chir; 1987 Jul; 42(13-14):1181-4. PubMed ID: 3670651
    [No Abstract]   [Full Text] [Related]  

  • 15. Soluble CD44: quantification and molecular repartition in plasma of patients with colorectal cancer.
    Masson D; Denis MG; Denis M; Blanchard D; Loirat MJ; Cassagnau E; Lustenberger P
    Br J Cancer; 1999 Aug; 80(12):1995-2000. PubMed ID: 10471052
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Colorectal cancer at Kent General Hospital, 1972-1976.
    Fitzpatrick PG
    Del Med J; 1979 Jan; 51(1):25-30. PubMed ID: 421945
    [No Abstract]   [Full Text] [Related]  

  • 17. Difference in Ulex europaeus agglutinin I-binding activity of decay-accelerating factor detected in the stools of patients with colorectal cancer and ulcerative colitis.
    Okazaki H; Mizuno M; Nasu J; Makidono C; Hiraoka S; Yamamoto K; Okada H; Fujita T; Tsuji T; Shiratori Y
    J Lab Clin Med; 2004 Mar; 143(3):169-74. PubMed ID: 15007307
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Staging: what makes sense? Can the pathologist help?
    Bernick PE; Wong WD
    Surg Oncol Clin N Am; 2000 Oct; 9(4):703-20; discussion 721-3. PubMed ID: 11008235
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Intraoperative staging of colorectal tumors].
    Abdurakhmonov IuB; Mel'nikov OR; Egorenkov VV; Moiseenko VM
    Vopr Onkol; 2007; 53(2):210-4. PubMed ID: 17663177
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Large intestinal neoplasms and pericancerous immunocompetent cells].
    Du ZY
    Zhonghua Yi Xue Za Zhi; 1985 Oct; 65(10):593-6. PubMed ID: 3938672
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.